272 related articles for article (PubMed ID: 24627433)
1. PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model.
Nomura S; Nozaki S; Hamazaki T; Takeda T; Ninomiya E; Kudo S; Hayashinaka E; Wada Y; Hiroki T; Fujisawa C; Kodama H; Shintaku H; Watanabe Y
J Nucl Med; 2014 May; 55(5):845-51. PubMed ID: 24627433
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram enhanced delivery of orally administered copper into the central nervous system in Menkes disease mouse model.
Hoshina T; Nozaki S; Hamazaki T; Kudo S; Nakatani Y; Kodama H; Shintaku H; Watanabe Y
J Inherit Metab Dis; 2018 Nov; 41(6):1285-1291. PubMed ID: 30132231
[TBL] [Abstract][Full Text] [Related]
3. Effect of copper and disulfiram combination therapy on the macular mouse, a model of Menkes disease.
Bhadhprasit W; Kodama H; Fujisawa C; Hiroki T; Ogawa E
J Trace Elem Med Biol; 2012 Jun; 26(2-3):105-8. PubMed ID: 22664332
[TBL] [Abstract][Full Text] [Related]
4. Copper-trafficking efficacy of copper-pyruvaldehyde bis(N4- methylthiosemicarbazone) on the macular mouse, an animal model of Menkes disease.
Munakata M; Kodama H; Fujisawa C; Hiroki T; Kimura K; Watanabe M; Nishikawa M; Tsuchiya S
Pediatr Res; 2012 Sep; 72(3):270-6. PubMed ID: 22728746
[TBL] [Abstract][Full Text] [Related]
5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
6. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
[TBL] [Abstract][Full Text] [Related]
7. Hepatic copper metabolism in a mouse model for Menkes' kinky hair syndrome.
Castillo RO; Thaler MM; O'Toole C; Packman S
Pediatr Res; 1990 May; 27(5):492-6. PubMed ID: 2345676
[TBL] [Abstract][Full Text] [Related]
8. Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease.
Kodama H; Sato E; Gu YH; Shiga K; Fujisawa C; Kozuma T
J Inherit Metab Dis; 2005; 28(6):971-8. PubMed ID: 16435190
[TBL] [Abstract][Full Text] [Related]
9. Effects of chelators on copper therapy of macular mouse, a model animal of Menkes' kinky disease.
Tanaka K; Kobayashi K; Fujita Y; Fukuhara C; Onosaka S; Min K
Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):217-27. PubMed ID: 2396048
[TBL] [Abstract][Full Text] [Related]
10. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
11. Imaging B Cells in a Mouse Model of Multiple Sclerosis Using
James ML; Hoehne A; Mayer AT; Lechtenberg K; Moreno M; Gowrishankar G; Ilovich O; Natarajan A; Johnson EM; Nguyen J; Quach L; Han M; Buckwalter M; Chandra S; Gambhir SS
J Nucl Med; 2017 Nov; 58(11):1845-1851. PubMed ID: 28687602
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Traumatic Brain Injury by Increased 64Cu Uptake on 64CuCl2 PET/CT.
Peng F; Muzik O; Gatson J; Kernie SG; Diaz-Arrastia R
J Nucl Med; 2015 Aug; 56(8):1252-7. PubMed ID: 26112025
[TBL] [Abstract][Full Text] [Related]
13. Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.
Cai H; Wu JS; Muzik O; Hsieh JT; Lee RJ; Peng F
J Nucl Med; 2014 Apr; 55(4):622-8. PubMed ID: 24639459
[TBL] [Abstract][Full Text] [Related]
14. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
[TBL] [Abstract][Full Text] [Related]
15. [Development of a therapeutic agent for Menkes disease: solubilization of a copper-disulfiram complex].
Hoshi Y; Tani N; Tabata H; Wakamatsu S; Munakata M; Maruyama K; Kodama H; Oshitari T; Natsugari H; Takahashi H
Yakugaku Zasshi; 2015; 135(3):493-9. PubMed ID: 25759057
[TBL] [Abstract][Full Text] [Related]
16. PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease.
Torres JB; Andreozzi EM; Dunn JT; Siddique M; Szanda I; Howlett DR; Sunassee K; Blower PJ
J Nucl Med; 2016 Jan; 57(1):109-14. PubMed ID: 26449834
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic demonstration of the copper-accumulating tissues in mice with a defect homologous to Menkes' Kinky Hair disease.
Delhez H; Prins HW; Prinsen L; van den Hamer CJ
Pathol Res Pract; 1983 Aug; 178(1):48-50. PubMed ID: 6417634
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
Persson M; Nedergaard MK; Brandt-Larsen M; Skovgaard D; Jørgensen JT; Michaelsen SR; Madsen J; Lassen U; Poulsen HS; Kjaer A
J Nucl Med; 2016 Feb; 57(2):272-8. PubMed ID: 26429955
[TBL] [Abstract][Full Text] [Related]
20. Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model.
Kim KI; Jang SJ; Park JH; Lee YJ; Lee TS; Woo KS; Park H; Choe JG; An GI; Kang JH
J Nucl Med; 2014 Oct; 55(10):1692-8. PubMed ID: 25091475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
